Arycs Technologies | $24,000,000 | (Mar 13, 2026)
Ezra(2) | $8,000,000 | (Mar 13, 2026)
Freestyle | $10,000,000 | (Mar 13, 2026)
Certified by Founder
Lodge
Infinitopes
start up
United Kingdom
- Oxford, Oxfordshire
- 21/01/2026
- Seed
- $15,400,000
Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.
- Industry Biotechnology Research
- Website https://www.infinitopes.com/
- LinkedIn https://www.linkedin.com/company/infinitopes/
Related People
Senthil ChinnakannanCo Founder
United Kingdom -
Oxford, England
Molecular virologist/vaccinologist with expertise in multiple antigen/epitope vaccine design for Adeno/MVA viral vectors, passionate about translational research. Interests: Adeno/MVA viral vectors, therapeutic hepatitis B vaccine, prophylactic hepatitis C vaccine, therapeutic cancer vaccine
Mantis Space | $10,000,000 | (Mar 13, 2026)
Monteris Medical | $28,000,000 | (Mar 13, 2026)
Gumloop | $50,000,000 | (Mar 13, 2026)
Combat Medical Ltd | $3,472,639 | (Mar 13, 2026)
Qurrent | $15,000,000 | (Mar 13, 2026)
Waiv, formerly Owkin Dx | $33,000,000 | (Mar 13, 2026)
Carefam | $14,500,000 | (Mar 13, 2026)
Option Circle | $3,000,000 | (Mar 12, 2026)
AgentMail (YC S25) | $6,000,000 | (Mar 12, 2026)